Aarvee Chem Profile
Key Indicators
- Authorised Capital ₹ 4.75 M
as on 30-07-2024
- Paid Up Capital ₹ 4.75 M
as on 30-07-2024
- Company Age 37 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.69 M
as on 30-07-2024
- Revenue 47.42%
(FY 2023)
- Profit 105.27%
(FY 2023)
- Ebitda 121.53%
(FY 2023)
- Net Worth 5.21%
(FY 2023)
- Total Assets 2.10%
(FY 2023)
About Aarvee Chem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.75 M and a paid-up capital of Rs 4.75 M.
The company currently has active open charges totaling ₹7.69 M.
Rangasamy Ramasamy and Mounagurusamy Kumar serve as directors at the Company.
- CIN/LLPIN
U02411TZ1987PTC001928
- Company No.
001928
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Mar 1987
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Dist Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aarvee Chem?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rangasamy Ramasamy | Managing Director | 20-Mar-1987 | Current |
Board Members(1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mounagurusamy Kumar | Director | 05-Jun-2008 | Current |
Financial Performance of Aarvee Chem.
Aarvee Chem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 47.42% increase. The company also saw a substantial improvement in profitability, with a 105.27% increase in profit. The company's net worth moved up by a moderate rise of 5.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Aarvee Chem?
In 2023, Aarvee Chem had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Palani Hospital And Research Centre Private LimitedActive 4 years 3 months
Mounagurusamy Kumar is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
The Catholic Syrian Bank Ltd Creation Date: 29 Apr 2005 | ₹6.00 M | Open |
The Tamilnadu Industrial Investment Co. Ltd Creation Date: 01 Mar 1989 | ₹0.26 M | Open |
The Tamilnadu Industrial Investment Co. Ltd Creation Date: 24 Nov 1988 | ₹1.44 M | Open |
How Many Employees Work at Aarvee Chem?
Unlock and access historical data on people associated with Aarvee Chem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aarvee Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aarvee Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.